HIGHLIGHTS
- who: Xiangling Xing and colleagues from the Department of Medicine, Division of Hematology, Bioclinicum, :, and Center for Molecular Medicine, Karolinska University Hospital Solna and Karolinska Institutet, , Solna, SwedenJinan, China have published the research: Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features, in the Journal: Cancers 2022, 14, 1385. of /2022/
- what: The present findings demonstrate that GABPB1 activates TERT expression on one hand, while it inhibits invasion and progression of TC on the other, which is very similar to its partner GABPA.
- future: It is thus conceivable that the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.